AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| 1 |
Amazon
AMZN
|
+$1.31B |
| 2 |
Nike
NKE
|
+$470M |
| 3 |
Visa
V
|
+$470M |
| 4 |
Etsy
ETSY
|
+$346M |
| 5 |
Gen Digital
GEN
|
+$257M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$669M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$517M |
| 3 |
Procter & Gamble
PG
|
+$388M |
| 4 |
IQVIA
IQV
|
+$299M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$298M |
Sector Composition
| 1 | Technology | 23.26% |
| 2 | Healthcare | 14.4% |
| 3 | Consumer Discretionary | 13.9% |
| 4 | Financials | 12.83% |
| 5 | Communication Services | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2701
ANI Pharmaceuticals
ANIP
$2.13B
| $633K | ﹤0.01% |
18,060
-3,609
| -17% | -$126K |
|
|
UBA
2702
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $633K | ﹤0.01% |
32,655
+10,202
| +45% | +$198K |
|
2703
Haverty Furniture Companies
HVT
$379M
| $631K | ﹤0.01% |
14,756
+2,750
| +23% | +$118K |
|
2704
First Foundation Inc
FFWM
$484M
| $630K | ﹤0.01% |
27,966
| – | – |
|
2705
Curis
CRIS
$22.5M
| $629K | ﹤0.01% |
+3,900
| New | +$629K |
|
2706
Stoneridge
SRI
$228M
| $628K | ﹤0.01% |
21,300
-1,200
| -5% | -$35.4K |
|
|
GTS
2707
DELISTED
Triple-S Management Corporation
GTS
| $628K | ﹤0.01% |
28,201
| – | – |
|
2708
LifeMD
LFMD
$284M
| $627K | ﹤0.01% |
+53,266
| New | +$627K |
|
|
ATRS
2709
DELISTED
Antares Pharma, Inc.
ATRS
| $627K | ﹤0.01% |
143,900
+11,600
| +9% | +$50.5K |
|
2710
Core Laboratories
CLB
$582M
| $626K | ﹤0.01% |
16,063
+6,310
| +65% | +$246K |
|
2711
Expro
XPRO
$1.42B
| $625K | ﹤0.01% |
34,383
| – | – |
|
2712
Vanguard FTSE All-World ex-US ETF
VEU
$49.4B
| $623K | ﹤0.01% |
9,829
-77
| -0.8% | -$4.88K |
|
2713
Acco Brands
ACCO
$357M
| $619K | ﹤0.01% |
71,733
+7,228
| +11% | +$62.4K |
|
2714
Camden National
CAC
$679M
| $619K | ﹤0.01% |
12,966
-1,400
| -10% | -$66.8K |
|
2715
Accuray
ARAY
$175M
| $617K | ﹤0.01% |
136,431
| – | – |
|
2716
Tidewater
TDW
$2.94B
| $613K | ﹤0.01% |
50,900
-1,100
| -2% | -$13.2K |
|
|
BPYU
2717
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $613K | ﹤0.01% |
32,426
-3,522
| -10% | -$66.6K |
|
2718
Vanguard Small-Cap Growth ETF
VBK
$20.3B
| $611K | ﹤0.01% |
2,107
-22
| -1% | -$6.38K |
|
|
TBCH
2719
Turtle Beach Corporation Common Stock
TBCH
$297M
| $610K | ﹤0.01% |
+19,095
| New | +$610K |
|
2720
Gannett
GCI
$598M
| $607K | ﹤0.01% |
110,601
+54,763
| +98% | +$301K |
|
2721
iShares MSCI USA Momentum Factor ETF
MTUM
$18.9B
| $607K | ﹤0.01% |
+3,500
| New | +$607K |
|
2722
BioAtla
BCAB
$40.6M
| $606K | ﹤0.01% |
14,300
+9,900
| +225% | +$420K |
|
2723
Tilly's
TLYS
$59.7M
| $605K | ﹤0.01% |
+37,875
| New | +$605K |
|
2724
Esperion Therapeutics
ESPR
$508M
| $604K | ﹤0.01% |
28,570
+4,800
| +20% | +$101K |
|
|
PENG
2725
Penguin Solutions, Inc. Ordinary Shares
PENG
$1.33B
| $604K | ﹤0.01% |
25,354
+7,700
| +44% | +$183K |
|